Checkpoint Therapeutics Ownership | Who Owns Checkpoint Therapeutics?
Checkpoint Therapeutics Ownership Summary
Checkpoint Therapeutics is owned by 25.62% institutional investors, 19.83% insiders, and 54.55% retail investors. Magnus financial group is the largest institutional shareholder, holding 0% of CKPT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.54% of its assets in Checkpoint Therapeutics shares.
CKPT Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Checkpoint Therapeutics | 25.62% | 19.83% | 54.55% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Magnus financial group | - | - | - |
Rothschild investment | - | - | - |
Bartlett & co. wealth management | - | - | - |
Legacy wealth asset management | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Magnus financial group | - | - | - |
Rothschild investment | - | - | - |
Bartlett & co. wealth management | - | - | - |
Legacy wealth asset management | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Rothschild investment | - | - | -10.00K |
Bartlett & co. wealth management | - | - | -19.00K |
Magnus financial group | - | - | -32.20K |
Legacy wealth asset management | - | - | -85.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Legacy wealth asset management | - | - | -85.00K |
Magnus financial group | - | - | -32.20K |
Bartlett & co. wealth management | - | - | -19.00K |
Rothschild investment | - | - | -10.00K |
Sold Out
Holder | Change |
---|---|
Rothschild investment | -10.00K |
Bartlett & co. wealth management | -19.00K |
Magnus financial group | -32.20K |
Legacy wealth asset management | -85.00K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 73 | 52.08% | 11,054,939 | 43.91% | 25 | 8.08% | 49 | 68.97% | 11 | 83.33% |
Sep 30, 2024 | 48 | - | 7,681,838 | 30.95% | 17 | 6.90% | 29 | 31.82% | 6 | -33.33% |
Jun 30, 2024 | 48 | 11.63% | 5,866,237 | 8.72% | 16 | 5.98% | 22 | - | 9 | -10.00% |
Mar 31, 2024 | 43 | -6.52% | 5,395,709 | 10.46% | 16 | 2.41% | 22 | -21.43% | 10 | - |
Dec 31, 2023 | 46 | 9.52% | 4,884,977 | 24.39% | 26 | 6.75% | 28 | 16.67% | 10 | 42.86% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.29M | 1.54% | 32.16K |
Vanguard US Total Market Shares ETF | 1.09M | 1.30% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 645.62K | 0.77% | -87.09K |
Fidelity Extended Market Index | 217.89K | 0.26% | -1.39K |
BlackRock Extended Equity Market K | 52.75K | 0.12% | -22.00 |
Extended Equity Market Fund K | 93.81K | 0.11% | 288.00 |
Accelerate Arbitrage ETF | 92.50K | 0.11% | 92.50K |
Northern Trust Extended Eq Market Idx | 44.82K | 0.09% | 10.23K |
iShares Micro-Cap ETF | 76.14K | 0.09% | - |
Spartan Extended Market Index Pool E | 71.38K | 0.09% | 1.39K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 02, 2025 | Oliviero James F III | CEO, President and Director | Sell | $60.96K |
Apr 01, 2025 | GRAY WILLIAM GARRETT | Chief Financial Officer | Sell | $49.90K |
Feb 07, 2025 | Oliviero James F III | CEO, President and Director | Sell | $31.48K |
Feb 10, 2025 | Oliviero James F III | CEO, President and Director | Sell | $32.54K |
Feb 06, 2025 | GRAY WILLIAM GARRETT | Chief Financial Officer | Sell | $271.98K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | 2 |
2025 Q1 | - | 3 |
2024 Q4 | - | 3 |
2024 Q3 | - | - |
2024 Q2 | - | 2 |
CKPT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools